2 article(s) from Karagkiozaki, Varvara
Figure 1: (a) Representative SEM micrographs of electrospun CA fibers, (b) AFM topography image of CA scaffol...
Figure 2: In vitro degradation of CA scaffolds as a function of the time.
Figure 3: Representative SEM micrographs of CA scaffolds (a) before degradation on the 1st day, (b) after deg...
Figure 4: (a) Representative SEM micrograph of electrospun CA:dexam fibers, (b) AFM topography image of CA:de...
Figure 5: In vitro degradation of CA scaffolds loaded with dexamethasone as function of the time.
Figure 6: Representative SEM micrographs of CA scaffolds (a) before degradation on the 1st day, (b) after deg...
Figure 7: In vitro release of dexamethasone.
Figure 8: MTT assay of L929 cells with the examined scaffolds after 1, 2 and 5 days.
Figure 9: Optical microscopy images of the cell morphology on the examined scaffolds. The three pictures in t...
Figure 10: SEM micrograph of L929 cells on the examined scaffolds. The three pictures in the top row display t...
Figure 11: Keithley microscopy images of (a) a blank orthopedic pin, (b) a pin coated with CA:dexam fibers and...
Figure 1: SEM and AFM images of the (a,d) untreated PCL electrospun scaffolds and of the O2-plasma modified o...
Figure 2: XPS spectra of the untreated PCL electrospun scaffolds and the O2-plasma modified ones, with P = 20...
Figure 3: The elastic modulus values of the untreated PCL electrospun scaffolds and the plasma-modified ones ...
Figure 4: (a,b) MTT assay of L929 cells in direct contact with the examined systems after 1, 3 and 7 days, in...
Figure 5: SEM micrographs of the (a–c) untreated PCL electrospun scaffolds for 1,3 and 7 days of direct conta...